跳转至内容
Merck
CN

M6536

MPL® + TDM Adjuvant

oil

别名:

Monophosphoryl-lipid A + Trehalose dicorynomycolate adjuvant

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352203
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


form

oil

storage temp.

2-8°C

General description

Each vial contains 0.5 mg monophosphoryl lipid A (detoxified endotoxin) from S. minnesota (MPL) and 0.5 mg synthetic trehalose dicorynomycolate (TDM) in 2% oil (squalene)-Tween 80-water.

Application

Ribi Adjuvant System (RAS) for use in mice.
RAS is a stable oil-in-water emulsion that may be used as an alternative to the water-in-oil emulsions. These adjuvants are derived from bacterial and mycobacterial cell wall components that have been prepared to reduce the undesirable side effects of toxicity and allergenicity, but still provide potent stimulus to the immune system.

Legal Information

MPL is a registered trademark of Corixa Corporation


存储类别

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Jun Takehisa et al.
Journal of virology, 81(14), 7463-7475 (2007-05-12)
Studies of simian immunodeficiency viruses (SIVs) in their endangered primate hosts are of obvious medical and public health importance, but technically challenging. Although SIV-specific antibodies and nucleic acids have been detected in primate fecal samples, recovery of replication-competent virus from
J Billington et al.
Journal of virology, 81(9), 4604-4614 (2007-02-16)
Stable trimeric forms of human immunodeficiency virus recombinant gp140 (rgp140) are important templates for determining the structure of the glycoprotein to assist in our understanding of HIV infection and host immune response. Such information will aid the design of therapeutic
F T Liang et al.
Infection and immunity, 69(3), 1337-1343 (2001-02-17)
VlsE, the variable surface antigen of the Lyme disease spirochete, Borrelia burgdorferi, contains two invariable domains, at the amino and carboxyl termini, respectively, which collectively account for approximately one-half of the entire molecule's length and remain unchanged during antigenic variation.